1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Peter Anderson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of ONC201 in Neuroendocrine Tumors ONC201 - Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor | Phase 2 | Completed | Peter Anderson | 30 | 2017-08-02 | 2024-11-26 |
TIC10 compound (1)
United States (1)